CEO of Dan­ish im­munother­a­py start­up hits the ex­it in the lat­est C-suite shake­up

Evax­ion Biotech, a Dan­ish start­up that us­es AI to de­vel­op per­son­al­ized im­muno-on­col­o­gy ther­a­pies, is shak­ing up its C-suite.

Lars Staal Weg­n­er has de­cid­ed to ex­it as the com­pa­ny’s CEO, Evax­ion an­nounced Tues­day, but will re­main in an ad­vi­so­ry role to the new CEO and board of di­rec­tors. Per Nor­lén, who has over 20 years in the in­dus­try, will take over as the new CEO in six months.

Pre­vi­ous­ly, Nor­lén was the CEO of Targin­ta and CMO of Xin­tela.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER